REVIEW
Published on 20 Mar 2025
MEPED as salvage therapy for relapsed/refractory Hodgkin’s lymphoma incorporating edited non-oncogene addiction: mTOR as a bottleneck
doi 10.3389/fphar.2025.1553331
- 839 views
- Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
- Research Topics
- Exploiting Non-Oncogene Addiction for Overcoming Drug Resistance in Metastatic Tumors
Exploiting Non-Oncogene Addiction for Overcoming Drug Resistance in Metastatic Tumors
2,612
Total downloads
11k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 25 Jun 2024
NDRG1 acts as an oncogene in triple-negative breast cancer and its loss sensitizes cells to mitochondrial iron chelation
doi 10.3389/fphar.2024.1422369
- 1,923 views
- 3 citations
REVIEW
Published on 20 Feb 2024
The anticancer activity of bile acids in drug discovery and development
doi 10.3389/fphar.2024.1362382
- 5,754 views
- 2 citations
